<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fractalkine (CX3CL1) and its receptor CX3CR1 play an important role in natural killer (NK) cell- and cytotoxic T cell-mediated endothelium damage </plain></SENT>
<SENT sid="1" pm="."><plain>Here we describe the cytotoxicity of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>)-derived T cell line, K2-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, through the fractalkine-CX3CR1 system </plain></SENT>
<SENT sid="2" pm="."><plain>K2-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cells induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> against CD34(+) cells from <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow (BM) in a direct cell contact manner </plain></SENT>
<SENT sid="3" pm="."><plain>K2-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cells expressed perforin and granzyme B, but they lacked Fas ligand expression </plain></SENT>
<SENT sid="4" pm="."><plain>A specific inhibitor for perforin, concanamycin A, blocked K2-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-dependent cytotoxicity </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, a CX3C-chemokine, fractalkine, was expressed in CD34(+) cells, and its receptor, CX3CR1, was expressed on K2-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>The neutralizing monoclonal antibody (MoAb) for fractalkine and soluble fractalkine significantly inhibited K2-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-dependent cytotoxicity </plain></SENT>
<SENT sid="7" pm="."><plain>K2-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cells also induced the cytotoxicity against human umbilical cord endothelial cells (HUVECs) expressing fractalkine </plain></SENT>
<SENT sid="8" pm="."><plain>These data indicate that K2-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> may be a perforin-granzyme-positive T cell line that exerts a cytotoxic effect on CD34(+) cells mediated through the fractalkine-CX3CR1 system </plain></SENT>
</text></document>